Back to the complete issue
Sunday, 12 December 2021

CI Capital’s Cleopatra bid gets regulatory approval

CI Capital’s bid to acquire 26.2% of Cleopatra Hospitals Group has received the greenlight from the Financial Regulatory Authority (FRA), the regulator said in a statement (pdf) to the EGX on Thursday. MCI Capital Healthcare Partners, the CI Capital subsidiary that’s executing the acquisition, submitted a voluntary tender offer last week to purchase the shares at EGP 5 apiece, valuing the company at EGP 8 bn.

The fair value of the company has not been assessed by an independent financial advisor, a source familiar with the matter told Enterprise. MCI’s offer is slightly higher than the company’s current share price, which eased 1% to EGP 4.65 on Thursday, according to market data.

The company’s biggest shareholder also gave a nod of approval: Creed Healthcare, which owns 37.9% of CHG through its subsidiary Care Healthcare, has agreed to sell an 8-12% stake in the company from its holdings (126 mn-192 mn shares). MCI will likely acquire the rest of the shares through the EGX.

The acquisition bid comes on the back of strong 2021 earnings for the healthcare company, which reported 58% y-o-y growth in net income during the first nine months of the year on the back of a 38% y-o-y rise in revenues.

BACKGROUND: CHG has been eyeing geographical expansion across Cairo: The EGX-listed healthcare company — one of the two largest in the private sector — recently purchased a brownfield project in East Cairo to develop into a 400-bed medical facility. CHG recently sought to expand its footprint through a mega-merger with private healthcare group Alameda, but the transaction fell through earlier this year. Cleopatra also acquired a 60% stake in Bedaya Hospital last year.

ADVISORS: Zulficar & Partners is acting as legal advisor to MCI Capital.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.